LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
15.60
+0.40 (2.63%)
Mar 10, 2026, 9:27 AM HKT
-17.89%
Market Cap 5.27B
Revenue (ttm) 605.14M
Net Income (ttm) 314.88M
Shares Out 346.75M
EPS (ttm) 0.91
PE Ratio 16.74
Forward PE 13.70
Dividend 0.67 (4.32%)
Ex-Dividend Date May 26, 2025
Volume 256,000
Average Volume 252,808
Open 15.58
Previous Close 15.20
Day's Range 14.92 - 15.60
52-Week Range 13.94 - 33.00
Beta -0.39
RSI 37.27
Earnings Date Mar 27, 2026

About HKG:2291

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the manufacture and sale of interventional treatment series occluders for defective congenital heart disease. It operates through Occluder Business and Heart Valve Business segments. The company also research and develops heart valve medical devices. Its products include atrial septal defect, ventricular septal defect, patent ductus arteriosus, patent foramen ovale, left atrial appendage, aortic and peripheral, and aortic and mitral valve occluder ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1994
Employees 374
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2291
Full Company Profile

Financial Performance

In 2024, HKG:2291's revenue was 471.64 million, an increase of 44.40% compared to the previous year's 326.62 million. Earnings were 245.56 million, an increase of 62.22%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.